UNITED STATES
                             SECURITIES AND EXCHANGE COMMISSION
                                   Washington, D.C. 20549

                                          FORM 8-K

                                       CURRENT REPORT
           Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

                              Date of Report: October 30, 2001

                                   Medix Resources, Inc.
                   (Exact name of registrant as specified in its charter)

         Colorado                        0-24768                    84-1123311
(State or other jurisdiction           (Commission                (IRS Employer
     of incorporation)                 File Number)             Identification No.)

         305 Madison Avenue, Suite 2033, New York, NY         10165
           (Address of principal executive offices)         (Zip Code)

         Registrant's telephone number, including area code: (212) 697-2509


            (Former name or former address, if changes since last report)

Item 5. Other Events.

                  Press release announcing Cymedix III, new technology available first
                  quarter 2002.

Exhibits

             Exhibit 99.1 - Copy of press release


                                         SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

                                              MEDIX RESOURCES, INC.

Date: October 30, 2001                    By: Gary L. Smith
                                              Executive Vice President and
                                              Chief Financial Officer